Fesoterodine and Itraconazole Interaction

Drug interaction information between Fesoterodine and Itraconazole.

Fesoterodine and Itraconazole have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Fesoterodine and Itraconazole. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Fesoterodine

Anticholinergic (Overactive Bladder)

Drug B

Itraconazole

Azole Antifungal

How They Interact

Itraconazole prevents the body from getting rid of fesoterodine, leading to higher amounts of the drug in your blood.

FDA Label Information

Fesoterodine Patients with moderate to severe renal or hepatic impairment : Contraindicated during and 2 weeks after itraconazole treatment.

Frequently Asked Questions

What SPL severity band is on file for Fesoterodine + Itraconazole?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Itraconazole has 116 labeled pairs on file vs Fesoterodine's 15. In the major band specifically: Fesoterodine has 2 (also Darunavir); Itraconazole has 19 (also Isavuconazonium, Lurasidone, Pimozide, Methadone).

What mechanism field is on file for Fesoterodine and Itraconazole?

Itraconazole prevents the body from getting rid of fesoterodine, leading to higher amounts of the drug in your blood.

Itraconazole carries more major-labeled pairs than Fesoterodine

SPL source-record counts only. This page's band is major · classes on file: Fesoterodine (Anticholinergic (Overactive Bladder)); Itraconazole (Azole Antifungal).

Itraconazole has 19 major-labeled pairs vs Fesoterodine's 2.

Fesoterodine

2 major · 2 moderate · 11 minor · 15 total

  • Other major peers for Fesoterodine
  • Darunavir
Itraconazole

19 major · 20 moderate · 77 minor · 116 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.